Trial intelligence / Profile preview

Effect of Magnesium Sulfate and Lidocaine on Cisatracurium-Induced Neuromuscular Blockade

NCT02483611Phase 4Completed

Sponsor
Universidade de São Paulo
Start
Jul 2015
Primary completion
Aug 2015
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of magnesium sulfate and lidocaine in neuromuscular blockade (NMB) (3 arms), sponsored by Universidade de São Paulo. Primary endpoints: Latency at 90 minutes, Clinical Duration at 90 minutes and 4 more. Started Jul 2015; status: completed.

02

Drugs

magnesium sulfatelidocaine
03

Conditions

neuromuscular blockade (NMB)

Beyond the preview

Go deeper on NCT02483611.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02483611.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call